Xometry Inc (XMTR)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Xometry Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 21 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 85.70 $ — 74% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 12.3% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 10
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.73 | 0.61 – 0.87 | 876 | 91.1% | 7 |
| 12/31/2027 | 1.37 | 1.13 – 1.93 | 1,047 | 88.2% | 8 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.08 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.20 | – | 149 | 15.90 | -6.70 | 9 | 5 |
| 2025: Q1 | -0.30 | – | 151 | 23.10 | -10.00 | -4 | -9 |
| 2025: Q2 | -0.52 | – | 163 | 22.60 | -16.30 | 0 | -7 |
| 2025: Q3 | -0.23 | – | 181 | 27.50 | -6.40 | 6 | -2 |
| 2025: Q4 | -0.17 | – | 192 | 29.50 | -4.50 | 4 | -6 |
| 2026: Q1 | -0.10 | – | 205 | 35.90 | -2.60 | 15 | 4 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | 80 | -31 | -31 | -0.70 | -27 | -73 | 77 |
| 2020 | 141 | -29 | -31 | -0.70 | -22 | -111 | 89 |
| 2021 | 218 | -59 | -61 | -1.32 | -69 | 424 | 503 |
| 2022 | 381 | -77 | -79 | -1.68 | -63 | 371 | 734 |
| 2023 | 463 | -74 | -67 | -1.41 | -30 | 329 | 707 |
| 2024 | 546 | -56 | -50 | -1.03 | -15 | 314 | 680 |
| 2025 | 687 | -46 | -62 | -1.22 | 6 | 276 | 704 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Xometry, Inc. betreibt einen KI-gestützten Online-Fertigungsmarktplatz in den USA und international.
| Employees | 1,174 |
|---|---|
| Headquarters | North Bethesda, MD |
| Address | 6116 Executive Boulevard, 20852 North Bethesda, United States |
| Phone | 240 252 1138 |
| Website | xometry.com |
| IPO Date | 30. Jun 2021 |
| ISIN | US98423F1093 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Randolph Brody Altschuler | Co-Founder & Executive Chair | 1971 |
| Sanjeev Singh Sahni | President, CEO & Director | 1976 |
| James Miln C.M.A. | CFO & Principal Accounting Officer | 1974 |
| Vaidyanathan Raghavan | Chief Technology Officer | 1982 |
| Subir Dutt | Chief Sales Officer | 1964 |
| Shawn Christopher Milne | Vice President of Investor Relations | – |
| Kristie Scott J.D. | Secretary & General Counsel | – |
| Stephany Verstraete | Chief Marketing Officer | 1969 |
| Kimberley Hirsch | Chief Human Resources Officer | – |
| Dmitry Kafidov | Managing Director of Xometry Europe | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.